Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 13/20 | 0.63 |
| ▸ | TTR | P02766 | 3/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CDC25A | P30304 | 1/20 | 0.39 |
| ▸ | CDC25C | P30307 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19802263 | 0.81 | AHR (0.59) | AHRTTRMCL1CA1CA2 | |
| SCHEMBL21638102 | 0.81 | TTR (0.47) | AHRTTRCDC25ACDC25C | |
| SCHEMBL21191893 | 0.81 | AHR (0.59) | AHRTTRMCL1CA1CA2 | |
| SCHEMBL24727144 | 0.81 | TTR (0.47) | AHRTTRCDC25ACDC25C | |
| SCHEMBL22156332 | 0.81 | TTR (0.47) | AHRTTR | |
| SCHEMBL24343623 | 0.81 | ALDH1A1 (0.59) | TTR | |
| SCHEMBL21669068 | 0.81 | AHR (0.59) | AHRTTRMCL1CA1CA2 | |
| SCHEMBL23203595 | 0.81 | TTR (0.47) | AHRTTR | |
| SCHEMBL21110463 | 0.81 | AHR (0.59) | AHRTTRMCL1 | |
| SCHEMBL2966509 | 0.81 | AHR (0.59) | AHRTTRMCL1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220140257-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2022-05-05 | — | — | US | disclosed |
| US-20190165282-A1 | HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES | MERCK PATENT GMBH (DE) | 2019-05-30 | — | — | US | disclosed |
| WO-2017178311-A1 | HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES | MERCK PATENT GMBH (DE) | 2017-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220140257-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OCIAD2, OCIAD1, OXER1 | AHR 1915/4885TTR 2530/4885MCL1 4523/4885 |
| US-20190165282-A1 | HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES | DDT, NUDT1, ETFB | AHR 959/4885TTR 1769/4885MCL1 2875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.